The Effect of Excess Weight Gain with Intensive Diabetes Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Study
暂无分享,去创建一个
J. Hokanson | B. Zinman | D. Nathan | J. Lachin | P. Cleary | J. Brunzell | J. Purnell
[1] Baqiyyah N. Conway,et al. Adiposity and Mortality in Type 1 Diabetes , 2009, International Journal of Obesity.
[2] Samir S. Deeb,et al. The Role of the PGC1α Gly482Ser Polymorphism in Weight Gain due to Intensive Diabetes Therapy , 2009, PPAR research.
[3] C. Forsblom,et al. Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes , 2009, Diabetes Care.
[4] J. Ilonen,et al. Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes , 2009, Diabetes Care.
[5] T. Orchard,et al. The Prediction of Major Outcomes of Type 1 Diabetes: a 12-Year Prospective Evaluation of Three Separate Definitions of the Metabolic Syndrome and Their Components and Estimated Glucose Disposal Rate , 2007, Diabetes Care.
[6] Matthias W. Lorenz,et al. Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis , 2007, Circulation.
[7] Mark A. Hlatky,et al. ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain , 2007 .
[8] David M Nathan,et al. The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study , 2006, Diabetes.
[9] S. Kurtoğlu,et al. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. , 2006, Diabetes research and clinical practice.
[10] Claude Bouchard,et al. The Human Obesity Gene Map: The 2005 Update , 2006, Obesity.
[11] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[12] R. Sacco,et al. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study , 2005, Diabetologia.
[13] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[14] F. Kaufman,et al. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. , 2004, The Journal of pediatrics.
[15] J. Brunzell,et al. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. , 2004, The Journal of clinical endocrinology and metabolism.
[16] Dana Dabelea,et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. , 2004, AJR. American journal of roentgenology.
[17] J. Hokanson,et al. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. , 2003, Diabetes care.
[18] J. Hokanson,et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. , 2003, Diabetes.
[19] I. Hirsch,et al. Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. , 2003, The Journal of clinical endocrinology and metabolism.
[20] D. O'leary,et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. , 2003, The New England journal of medicine.
[21] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[22] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[23] D. Rader,et al. A novel endothelial-derived lipase that modulates HDL metabolism , 1999, Nature Genetics.
[25] P A Cleary,et al. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. , 1998, JAMA.
[26] L. Kuller,et al. The Association Between a Family History of Type 2 Diabetes and Coronary Artery Disease in a Type 1 Diabetes Population , 1998, Diabetes Care.
[27] C. Bouchard,et al. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[28] C. Bouchard,et al. Familial aggregation of abdominal visceral fat level: results from the Quebec family study. , 1996, Metabolism: clinical and experimental.
[29] Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. , 1995, The American journal of cardiology.
[30] B. Föger,et al. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase. , 1994, Journal of lipid research.
[31] P. Subbaiah,et al. Accelerated cholesteryl ester transfer in patients with insulin‐dependent diabetes mellitus , 1991, European journal of clinical investigation.
[32] The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. , 1986, Diabetes.
[33] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.